Theravance Biopharma, Inc. (TBPH)
20.37
+0.36
(+1.80%)
USD |
NASDAQ |
Jan 20, 16:00
20.37
0.00 (0.00%)
After-Hours: 19:41
Theravance Biopharma Price: 20.37 for Jan. 20, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Corcept Therapeutics, Inc. | 35.28 |
| Perspective Therapeutics, Inc. | 2.43 |
| Skye Bioscience, Inc. | 0.9737 |
| Kyntra Bio, Inc. | 8.81 |
| Myomo, Inc. | 0.9749 |
Price Related Metrics
| PE Ratio | 36.21 |
| PS Ratio | 12.78 |
| Price to Book Value | 4.436 |
| Price to Free Cash Flow | 4.218 |
| Earnings Yield | 2.76% |
| Market Cap | 1.032B |
| Normalized PE Ratio | 36.21 |